Nov.25 -- Teva Pharmaceuticals Industries Ltd. and other generic drugmakers have held talks with the U.S. Justice Department about resolving a criminal anti-trust probe of alleged price fixing by the companies. Bloomberg’s Kailey Leinz reports on “Balance of Power.”
Teva, Others in Talks With DOJ to End Generic Drug Probe
Nov.25 -- Teva Pharmaceuticals Industries Ltd. and other generic drugmakers have held talks with the U.S. Justice Department about resolving a criminal anti-trust probe of alleged price fixing by the companies. Bloomberg’s Kailey Leinz reports on “Balance of Power.”
0 Comments